Offer self administered DMPA subcutaneous injection as alternative using shared decision making 3 nbsp nbsp May improve contraceptive access and uarr reproductive autonomy nbsp nbsp Recommendations same as for clinician administered DMPA nbsp nbsp No f u

Offer self-administered DMPA subcutaneous injection as alternative, using shared decision-making.³<br>
&nbsp;&nbsp;◦ May improve contraceptive access and &uarr; reproductive autonomy<br>
&nbsp;&nbsp;◦ Recommendations same as for clinician-administered DMPA<br>
&nbsp;&nbsp;◦ No f/u needed<br>
&nbsp;&nbsp;◦ Self-administration is “off-label”<br>
&nbsp;&nbsp;◦ Higher rates of continuation vs. clinician-administered DMPA<br>
&nbsp;&nbsp;◦ Pregnancy rates low, similar to clinician-administered DMPA<br>
&nbsp;&nbsp;◦ May have higher rate of injection-site reactions but no &uarr; in other side effects/adverse events